• Our Team
  • GP Symposium 2025
  • GP Heart Blog
  • Patient Info
  • New patient form
  • Contact
Menu

Cardiology Institute

Unit 109, 119 Apollo Drive, Albany, Auckland
consult@cardiologist.co.nz
P: xxx-xxxx; F xxx-xxxx
Unit 109, 119 Apollo Drive, Albany, Auckland. P: 000-0000. F: 000-0000. consult@cardiologist.co.nz. EDI: cardinst

T 09-980-6363. M 022-672-8255. F 09-929-3248. consult@cardiologist.co.nz. EDI: CARDINST

North Shore - Suite 109, Level 1, 119 Apollo Drive, Albany

Silverdale - Northern Specialist Centre @Beyond; 5 Painton Road, Silverdale.

Central Auckland - 110 Specialist Centre @ Beyond;v110 Grafton Road, Grafton

East Auckland - East Care Specialist Centre, 260 Botany Road, Howick, Manukau

Cardiology Institute

  • Our Team
  • GP Symposium 2025
  • GP Heart Blog
  • Patient Info
  • New patient form
  • Contact

Heart failure medications - dosages

February 17, 2024 Andrew To
Iris Iris Iris by Dane Mitchell @ Auckland Art Gallery 2019

Iris Iris Iris by Dane Mitchell @ Auckland Art Gallery 2019

Heart failure medications save lives.

Dosages are important though, and many patients may not be on sufficient dosages.

Here are a number of tables useful for references, adapted from ACC/AHA guidelines 2013.

Read more
In Heart Failure, Drug Treatment Tags heart failure, beta blocker, ACE inhibitor
Comment

What should I do with heart failure with preserved ejection fraction?

September 7, 2019 Andrew To
Homage to Mondrian by Nipan Keawkumdee

Homage to Mondrian by Nipan Keawkumdee

HFpEF stands for heart failure with preserved ejection fraction. Commonly, it is defined as those with an LV ejection fraction of more than 50%, though varying definitions do exist.

This condition is poorly understood and is difficult to diagnose, because it is largely one of excluding other potential non cardiac causes of symptoms suggestive of HF.

Read more
In Drug Treatment, Hypertension Tags heart failure, hypertension, beta-blocker, ACE inhibitor, woman

Hypertension treatment – how should we choose?

September 6, 2019 Andrew To
Billy Apple @ Auckland Art Gallery 2015 (2 Minutes 33 Seconds (Red))

Billy Apple @ Auckland Art Gallery 2015 (2 Minutes 33 Seconds (Red))

First line agents for hypertension are one of three classes:

-       ACE inhibitors or Angiotensin receptor blockers

-       Thiazides

-       Calcium channel blockers

Drug preference is mainly influenced by co-morbidities and contraindications, rather than a simple age cut-off. 

Read more
In Hypertension, Drug Treatment Tags beta blocker, ACE inhibitor, calcium channel blocker, hypertension, thiazide

Beta-blockers in Hypertension

September 5, 2019 Andrew To

70-year-old asymptomatic man with hypertension but not cardiovascular disease presented for a routine check. His pulse rate was 40bpm.  His son, aged 45, recently had an MI in Australia.

His medications include

  • Doxazosin 8mg OD

  • Metoprolol 95mg CR OD – since 2006

  • Cilazapril 5mg / Hydrochlorothiazide 12.5mg OD

ECG shows sinus bradycardia, with normal PR interval, QRS duration.

Read more
In Drug Treatment Tags hypertension, beta-blocker, calcium channel blocker, ACE inhibitor, angina, coronary artery disease, heart failure

BP therapy initiation - Combination vs. Single Agent

September 4, 2019 Andrew To
Expected BP lowering with different anti-hypertensive classes and dosages.

Expected BP lowering with different anti-hypertensive classes and dosages.

65M with Type 2 diabetes on oral hypoglycaemics but no proven coronary artery disease, BP 150/95mmHg despite 3 months of intensive lifestyle modifications, not currently on anti-hypertensives. Would you?

-      Introduce low dose ACE inhibitors, with gradual up-titration

-      Introduce combination ACE inhibitor / thiazide, with up-titration later on

Read more
In Drug Treatment, Hypertension Tags hypertension, Side effects, calcium channel blocker, ACE inhibitor, thiazide, beta blocker, primary prevention

ACC AHA Hypertension Guidelines 2017 – What’s new?

February 1, 2018 Andrew To
@ AHA Meeting in Anaheim 2017 - taking notes

@ AHA Meeting in Anaheim 2017 - taking notes

The ACC/AHA Hypertension Guidelines 2017 was released in the AHA meeting in Anaheim, Californiain November 2017.

While there were a lot of changes, I think it has simplified a lot of the complexities surrounding treatment threshold and goal.

Read more
In Drug Treatment, Hypertension Tags hypertension, calcium channel blocker, ACE inhibitor, beta blocker

Copyright @2024 Cardiology Institute; All photos copyright @2024 Andrew To